Figure 1. The relationship between Estimate/immune/stromal score and the prognosis of LUAD samples from TCGA.

(A) Estimate score was significantly associated with pathological stage (p = 0.0436). (B) Immune score showed predictive potential to pathological stage (p = 0.026). (C) Similarly, the lowest stromal score was found in the most progressive clinicopathological stage IV, however, it was not statistically significant (p = 0.145). (D) Immune score was significantly correlated with overall survival of LUAD samples (p = 0.015). (E) Stromal score was not statistically significant correlated with overall, but the median overall survival of cases with higher stromal scores also showed longer than the patients with lower stromal scores (1830 d vs 1293 d, p = 0.0599, p = 0.145).